Due to the significantly increased miR-134 levels in PBMCs from AOSD patients after TLR3 ligand poly (I:C) treatment (Fig. 1e), we further examined the levels of IL-18BP in PBMCs following poly (I:C) treatment. This evidence concerns the gene TLR3 and adult-onset Still disease.